State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Sciences, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, 200031, China.
Department of Pathogenic Biology, School of Basic Medical Science, China Medical University, Shenyang, 110001, China.
Signal Transduct Target Ther. 2023 Aug 23;8(1):311. doi: 10.1038/s41392-023-01546-w.
As key organelles involved in cellular metabolism, mitochondria frequently undergo adaptive changes in morphology, components and functions in response to various environmental stresses and cellular demands. Previous studies of mitochondria research have gradually evolved, from focusing on morphological change analysis to systematic multiomics, thereby revealing the mitochondrial variation between cells or within the mitochondrial population within a single cell. The phenomenon of mitochondrial variation features is defined as mitochondrial heterogeneity. Moreover, mitochondrial heterogeneity has been reported to influence a variety of physiological processes, including tissue homeostasis, tissue repair, immunoregulation, and tumor progression. Here, we comprehensively review the mitochondrial heterogeneity in different tissues under pathological states, involving variant features of mitochondrial DNA, RNA, protein and lipid components. Then, the mechanisms that contribute to mitochondrial heterogeneity are also summarized, such as the mutation of the mitochondrial genome and the import of mitochondrial proteins that result in the heterogeneity of mitochondrial DNA and protein components. Additionally, multiple perspectives are investigated to better comprehend the mysteries of mitochondrial heterogeneity between cells. Finally, we summarize the prospective mitochondrial heterogeneity-targeting therapies in terms of alleviating mitochondrial oxidative damage, reducing mitochondrial carbon stress and enhancing mitochondrial biogenesis to relieve various pathological conditions. The possibility of recent technological advances in targeted mitochondrial gene editing is also discussed.
线粒体作为参与细胞代谢的关键细胞器,经常会在形态、成分和功能上发生适应性变化,以响应各种环境压力和细胞需求。线粒体研究的先前研究已经逐渐发展,从专注于形态变化分析到系统的多组学,从而揭示了细胞之间或单个细胞内线粒体群体之间的线粒体变化。线粒体变化特征的现象被定义为线粒体异质性。此外,已经报道线粒体异质性会影响多种生理过程,包括组织动态平衡、组织修复、免疫调节和肿瘤进展。在这里,我们全面综述了病理状态下不同组织中的线粒体异质性,涉及线粒体 DNA、RNA、蛋白质和脂质成分的变异特征。然后,还总结了导致线粒体 DNA 和蛋白质成分异质性的机制,例如线粒体基因组的突变和线粒体蛋白的输入。此外,还从多个角度探讨了更好地理解细胞间线粒体异质性之谜。最后,我们总结了针对线粒体异质性的治疗方法的前景,包括减轻线粒体氧化损伤、减少线粒体碳应激和增强线粒体生物发生,以缓解各种病理状况。还讨论了靶向线粒体基因编辑的最新技术进展的可能性。